SBLENDORIO GLENN
Insider CIK 1277478 · MDCO President & CFO, Director · FOLD Director · ICPT Director · OPHT President, CFO and Treasurer, Director · FDMT Director · MLYS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2026-06-17 | 2026-06-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 20,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 16,236 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 19,473 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 18,574 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 36,111 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 45,423 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 30,474 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 42,467 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 74,872 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer | 2026-04-27 | 2026-04-27 | 142,564 | $14.50 | $2.07M | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2026-02-19 | 2026-02-20 | 8,300 | — | $0 | 8,300 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2026-02-19 | 2026-02-20 | 6,200 | — | $0 | 6,200 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2026-01-05 | 2026-01-07 | 45,000 | — | $0 | 45,000 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2025-06-05 | 2025-06-06 | 74,872 | — | $0 | 74,872 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2025-06-05 | 2025-06-06 | 20,414 | — | $0 | 115,857 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2025-02-13 | 2025-02-24 | 32,900 | — | $0 | 32,900 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2024-06-06 | 2024-06-07 | 42,467 | — | $0 | 42,467 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2024-06-06 | 2024-06-07 | 11,847 | — | $0 | 95,443 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2024-05-22 | 2024-05-23 | 22,000 | — | $0 | 22,000 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise deriv | 2024-03-07 | 2024-03-11 | 15,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise | 2024-03-07 | 2024-03-11 | 15,000 | $2.80 | $42.0K | 83,596 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 1,750 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 12,089 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 12,790 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 12,547 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 551 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,966 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 1,598 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,036 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,748 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,174 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer | 2023-11-08 | 2023-11-13 | 8,111 | $19.00 | $154.1K | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | U Tender | 2023-11-08 | 2023-11-13 | 23,447 | $19.00 | $445.5K | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2023-09-13 | 2023-09-14 | 44,000 | — | $0 | 44,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 23,750 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 73,315 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 15,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 6,949 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 150,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 150,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 300,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 252,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 293,150 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 190,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 133,500 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 325,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 260,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 94,500 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 7,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer | 2023-07-11 | 2023-07-13 | 239,275 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2023-06-22 | 2023-06-26 | 11,084 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2023-06-22 | 2023-06-26 | 11,084 | $13.22 | $146.5K | 239,275 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2023-06-08 | 2023-06-12 | 30,474 | — | $0 | 30,474 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2023-06-08 | 2023-06-12 | 8,584 | — | $0 | 95,303 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2023-05-24 | 2023-05-25 | 12,547 | — | $0 | 12,547 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2023-05-24 | 2023-05-25 | 8,111 | — | $0 | 31,558 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise deriv | 2023-05-18 | 2023-05-19 | 15,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise | 2023-05-18 | 2023-05-19 | 15,000 | $3.32 | $49.8K | 86,719 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2023-01-03 | 2023-01-04 | 17,447 | $20.06 | $350.0K | 228,191 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2023-01-02 | 2023-01-04 | 31,500 | — | $0 | 94,500 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2023-01-02 | 2023-01-04 | 31,500 | — | $0 | 245,638 | SEC↗ |
| ISEE IVERIC bio, Inc. | G Gift | 2022-12-27 | 2022-12-29 | 30,000 | — | $0 | 214,138 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2022-12-20 | 2022-12-22 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2022-12-20 | 2022-12-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2022-12-19 | 2022-12-20 | 19,457 | $21.51 | $418.5K | 244,138 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2022-12-18 | 2022-12-20 | 36,658 | — | $0 | 73,314 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2022-12-18 | 2022-12-20 | 36,658 | — | $0 | 263,595 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2022-12-12 | 2022-12-13 | 22,950 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2022-12-12 | 2022-12-13 | 22,950 | — | $0 | 226,937 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2022-12-09 | 2022-12-13 | 23,750 | — | $0 | 23,750 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2022-12-09 | 2022-12-13 | 23,750 | — | $0 | 203,987 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2022-11-02 | 2022-11-04 | 50,000 | $23.01 | $1.15M | 179,689 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2022-06-09 | 2022-06-10 | 45,423 | — | $0 | 45,423 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2022-06-09 | 2022-06-10 | 12,671 | — | $0 | 71,719 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2022-05-25 | 2022-05-27 | 12,790 | — | $0 | 12,790 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2022-05-25 | 2022-05-27 | 7,737 | — | $0 | 23,447 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2022-04-04 | 2022-04-06 | 50,000 | $18.76 | $938.0K | 229,689 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2022-04-01 | 2022-04-01 | 40,756 | — | $0 | 325,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2022-04-01 | 2022-04-01 | 40,756 | $17.50 | $713.2K | 279,689 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2022-04-01 | 2022-04-01 | 40,756 | $2.94 | $119.8K | 320,445 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2022-03-31 | 2022-04-01 | 1,400 | — | $0 | 365,756 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2022-03-31 | 2022-04-01 | 1,400 | $17.02 | $23.8K | 279,689 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2022-03-31 | 2022-04-01 | 1,400 | $2.94 | $4.1K | 281,089 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2022-03-30 | 2022-04-01 | 1,213 | — | $0 | 367,156 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2022-03-30 | 2022-04-01 | 1,213 | $2.94 | $3.6K | 280,902 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2022-03-30 | 2022-04-01 | 1,213 | $17.00 | $20.6K | 279,689 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2022-03-25 | 2022-03-29 | 18,775 | — | $0 | 368,369 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2022-03-25 | 2022-03-29 | 18,775 | $17.06 | $320.3K | 279,689 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2022-03-25 | 2022-03-29 | 18,775 | $2.94 | $55.2K | 298,464 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2022-03-18 | 2022-03-22 | 3,479 | — | $0 | 387,144 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2022-03-18 | 2022-03-22 | 3,479 | $17.00 | $59.1K | 279,689 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2022-03-18 | 2022-03-22 | 3,479 | $2.94 | $10.2K | 283,168 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise deriv | 2022-03-04 | 2022-03-07 | 15,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | M Exercise | 2022-03-04 | 2022-03-07 | 15,000 | $4.79 | $71.8K | 59,048 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2021-12-31 | 2022-01-03 | 801 | — | $0 | 390,623 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2021-12-31 | 2022-01-03 | 801 | $2.94 | $2.4K | 279,934 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2021-12-31 | 2022-01-03 | 801 | $17.01 | $13.6K | 279,133 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2021-12-30 | 2022-01-03 | 100 | — | $0 | 391,424 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2021-12-30 | 2022-01-03 | 100 | $17.01 | $1.7K | 279,133 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2021-12-30 | 2022-01-03 | 100 | $2.94 | $294 | 279,233 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2021-12-27 | 2021-12-27 | 5,229 | — | $0 | 133,500 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2021-12-27 | 2021-12-27 | 5,229 | $16.64 | $87.0K | 279,133 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2021-12-27 | 2021-12-27 | 5,229 | $1.45 | $7.6K | 284,362 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2021-12-23 | 2021-12-27 | 8,476 | — | $0 | 391,524 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2021-12-23 | 2021-12-27 | 22,608 | — | $0 | 138,729 | SEC↗ |
| ISEE IVERIC bio, Inc. | G Gift | 2021-12-23 | 2021-12-27 | 20,000 | — | $0 | 299,133 | SEC↗ |
| ISEE IVERIC bio, Inc. | G Gift | 2021-12-23 | 2021-12-27 | 20,000 | — | $0 | 279,133 | SEC↗ |
| ISEE IVERIC bio, Inc. | G Gift | 2021-12-23 | 2021-12-27 | 20,000 | — | $0 | 319,133 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2021-12-23 | 2021-12-27 | 31,084 | $16.96 | $527.2K | 339,133 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2021-12-23 | 2021-12-27 | 8,476 | $2.94 | $24.9K | 370,217 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2021-12-23 | 2021-12-27 | 22,608 | $1.45 | $32.8K | 361,741 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2021-12-22 | 2021-12-27 | 22,163 | — | $0 | 161,337 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2021-12-22 | 2021-12-27 | 22,163 | $1.45 | $32.1K | 361,296 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 22,163 | $16.50 | $365.7K | 339,133 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2021-12-20 | 2021-12-21 | 18,524 | $15.44 | $286.0K | 339,133 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2021-12-18 | 2021-12-21 | 36,658 | — | $0 | 109,972 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2021-12-18 | 2021-12-21 | 36,658 | — | $0 | 357,657 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2021-12-16 | 2021-12-20 | 252,000 | — | $0 | 252,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2021-12-16 | 2021-12-20 | 126,000 | — | $0 | 126,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2021-12-13 | 2021-12-14 | 8,293 | $14.74 | $122.2K | 320,999 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2021-12-12 | 2021-12-14 | 22,950 | — | $0 | 22,950 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2021-12-12 | 2021-12-14 | 22,950 | — | $0 | 329,292 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2021-12-09 | 2021-12-13 | 23,750 | — | $0 | 47,500 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2021-12-09 | 2021-12-13 | 23,750 | — | $0 | 306,342 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 36,111 | — | $0 | 36,111 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2021-06-10 | 2021-06-14 | 10,115 | — | $0 | 44,048 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2021-05-27 | 2021-06-01 | 12,089 | — | $0 | 12,089 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-05-27 | 2021-06-01 | 7,029 | — | $0 | 15,710 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2020-12-18 | 2020-12-22 | 146,630 | — | $0 | 146,630 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2020-12-18 | 2020-12-22 | 293,130 | — | $0 | 293,130 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2020-12-12 | 2020-12-15 | 22,950 | — | $0 | 45,900 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2020-12-12 | 2020-12-15 | 22,950 | — | $0 | 273,773 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2020-12-09 | 2020-12-11 | 23,750 | — | $0 | 71,250 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2020-12-09 | 2020-12-11 | 23,750 | — | $0 | 250,823 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2020-06-04 | 2020-06-08 | 18,574 | — | $0 | 18,574 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2020-06-04 | 2020-06-08 | 5,855 | — | $0 | 33,933 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2020-05-28 | 2020-06-01 | 2,966 | — | $0 | 2,966 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2020-05-28 | 2020-06-01 | 1,595 | — | $0 | 8,681 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2020-04-01 | 2020-04-03 | 18,750 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2020-04-01 | 2020-04-03 | 18,750 | — | $0 | 225,061 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2019-12-12 | 2019-12-16 | 22,950 | — | $0 | 68,850 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2019-12-12 | 2019-12-16 | 22,950 | — | $0 | 199,804 | SEC↗ |
| ISEE IVERIC bio, Inc. | P Buy | 2019-12-10 | 2019-12-11 | 62,500 | $4.00 | $250.0K | 176,854 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2019-12-09 | 2019-12-11 | 95,000 | — | $0 | 95,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2019-12-09 | 2019-12-11 | 190,000 | — | $0 | 190,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | P Buy | 2019-11-15 | 2019-11-18 | 15,000 | $3.12 | $46.8K | 114,354 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2019-06-27 | 2019-07-01 | 19,473 | — | $0 | 19,473 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2019-06-27 | 2019-07-01 | 6,250 | — | $0 | 28,078 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2019-06-20 | 2019-06-21 | 2,174 | — | $0 | 2,174 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2019-06-20 | 2019-06-21 | 1,570 | — | $0 | 7,086 | SEC↗ |
| ISEE IVERIC bio, Inc. | P Buy | 2019-05-10 | 2019-05-13 | 25,000 | $1.48 | $37.0K | 93,105 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2019-04-02 | 2019-04-03 | 6,914 | $1.43 | $9.9K | 68,105 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise deriv | 2019-04-01 | 2019-04-03 | 18,750 | — | $0 | 18,750 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise | 2019-04-01 | 2019-04-03 | 18,750 | — | $0 | 75,019 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2018-12-12 | 2018-12-14 | 91,800 | — | $0 | 91,800 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2018-12-12 | 2018-12-14 | 183,500 | — | $0 | 183,500 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2018-06-20 | 2018-06-22 | 2,748 | — | $0 | 2,748 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2018-06-20 | 2018-06-22 | 1,787 | — | $0 | 5,516 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2018-06-07 | 2018-06-11 | 8,912 | — | $0 | 8,912 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award | 2018-06-07 | 2018-06-11 | 3,081 | — | $0 | 8,895 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2018-04-02 | 2018-04-03 | 6,838 | $2.69 | $18.4K | 48,407 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise deriv | 2018-04-01 | 2018-04-03 | 18,750 | — | $0 | 37,500 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise | 2018-04-01 | 2018-04-03 | 18,750 | — | $0 | 55,245 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2018-01-02 | 2018-01-03 | 8,089 | $3.19 | $25.8K | 36,495 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise deriv | 2017-12-29 | 2018-01-03 | 20,420 | — | $0 | 0 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise | 2017-12-29 | 2018-01-03 | 20,420 | — | $0 | 44,584 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2017-12-19 | 2017-12-21 | 400,000 | — | $0 | 400,000 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2017-07-05 | 2017-07-05 | 7,828 | $2.58 | $20.2K | 24,164 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise deriv | 2017-06-30 | 2017-07-05 | 20,420 | — | $0 | 20,420 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise | 2017-06-30 | 2017-07-05 | 20,420 | — | $0 | 31,992 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2017-06-27 | 2017-06-29 | 2,036 | — | $0 | 2,036 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2017-06-27 | 2017-06-29 | 1,423 | — | $0 | 3,729 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2017-06-13 | 2017-06-15 | 16,236 | — | $0 | 16,236 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award | 2017-06-13 | 2017-06-15 | 5,814 | — | $0 | 17,747 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2017-04-03 | 2017-04-04 | 7,388 | $3.56 | $26.3K | 11,572 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise deriv | 2017-04-01 | 2017-04-04 | 18,750 | — | $0 | 56,250 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise | 2017-04-01 | 2017-04-04 | 18,750 | — | $0 | 18,960 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2017-01-30 | 2017-02-01 | 260,000 | — | $0 | 260,000 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2017-01-17 | 2017-01-19 | 40,840 | — | $0 | 40,840 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2016-12-22 | 2016-12-23 | 1,079 | $4.85 | $5.2K | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2016-07-19 | 2016-07-21 | 1,598 | — | $0 | 1,598 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2016-07-19 | 2016-07-21 | 1,204 | — | $0 | 2,306 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2016-06-09 | 2016-06-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2016-06-02 | 2016-06-03 | 671 | $57.20 | $38.4K | 1,079 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise deriv | 2016-06-01 | 2016-06-03 | 1,750 | — | $0 | 0 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise | 2016-06-01 | 2016-06-03 | 1,750 | — | $0 | 1,750 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2016-04-01 | 2016-04-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2016-04-01 | 2016-04-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise deriv | 2015-12-30 | 2016-01-04 | 2,000 | — | $0 | 11,084 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-12-30 | 2016-01-04 | 2,000 | $80.00 | $160.0K | 0 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise | 2015-12-30 | 2016-01-04 | 2,000 | $13.22 | $26.4K | 2,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2015-11-24 | 2015-11-27 | 1,750 | — | $0 | 1,750 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2015-11-24 | 2015-11-27 | 650 | — | $0 | 1,102 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2015-09-03 | 2015-09-04 | 25,000 | — | $0 | 43,000 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2015-09-03 | 2015-09-04 | 25,000 | $42.00 | $1.05M | 99,805 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2015-09-03 | 2015-09-04 | 25,000 | $22.04 | $551.0K | 124,805 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2015-08-31 | 2015-09-02 | 50,000 | — | $0 | 15,000 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2015-08-31 | 2015-09-02 | 24,495 | — | $0 | 0 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2015-08-31 | 2015-09-02 | 40,000 | — | $0 | 0 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2015-08-31 | 2015-09-02 | 266 | $24.74 | $6.6K | 99,805 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2015-08-31 | 2015-09-02 | 40,000 | $28.60 | $1.14M | 139,805 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2015-08-31 | 2015-09-02 | 24,495 | $19.36 | $474.2K | 164,300 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2015-08-31 | 2015-09-02 | 50,000 | $17.45 | $872.5K | 214,300 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2015-08-31 | 2015-09-02 | 114,495 | $39.75 | $4.55M | 99,805 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise deriv | 2015-07-17 | 2015-07-20 | 2,000 | — | $0 | 13,084 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-07-17 | 2015-07-20 | 2,000 | $70.00 | $140.0K | 0 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise | 2015-07-17 | 2015-07-20 | 2,000 | $13.22 | $26.4K | 2,000 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-07-16 | 2015-07-20 | 1,000 | $62.00 | $62.0K | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise deriv | 2015-07-13 | 2015-07-15 | 10,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | S Sale | 2015-07-13 | 2015-07-15 | 10,000 | $15.00 | $150.0K | 11,933 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise | 2015-07-13 | 2015-07-15 | 10,000 | $15.00 | $150.0K | 21,933 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2015-06-25 | 2015-06-26 | 3,305 | $32.00 | $105.8K | 99,539 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2015-06-10 | 2015-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2015-06-04 | 2015-06-08 | 7,000 | — | $0 | 7,000 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2015-06-04 | 2015-06-08 | 1,750 | — | $0 | 1,750 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise deriv | 2015-04-15 | 2015-04-17 | 10,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise deriv | 2015-04-15 | 2015-04-17 | 10,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | S Sale | 2015-04-15 | 2015-04-17 | 20,000 | $12.50 | $250.0K | 11,933 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise | 2015-04-15 | 2015-04-17 | 20,000 | $12.50 | $250.0K | 31,933 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2015-03-23 | 2015-03-25 | 34,773 | $30.78 | $1.07M | 102,844 | SEC↗ |
| MDCO MEDICINES CO /DE | F Tax w/h | 2015-03-02 | 2015-03-03 | 8,138 | $28.93 | $235.4K | 137,617 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award deriv | 2015-03-01 | 2015-03-03 | 93,750 | — | $0 | 93,750 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2015-03-01 | 2015-03-03 | 15,641 | — | $0 | 145,755 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2015-02-27 | 2015-03-03 | 475 | $22.32 | $10.6K | 130,114 | SEC↗ |
| MDCO MEDICINES CO /DE | F Tax w/h | 2015-02-24 | 2015-02-26 | 4,008 | $28.67 | $114.9K | 129,639 | SEC↗ |
| MDCO MEDICINES CO /DE | F Tax w/h | 2015-02-18 | 2015-02-20 | 1,672 | $28.37 | $47.4K | 133,647 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2014-08-29 | 2014-09-03 | 295 | $21.77 | $6.4K | 135,319 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise deriv | 2014-08-27 | 2014-08-29 | 10,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | S Sale | 2014-08-27 | 2014-08-29 | 10,000 | $6.50 | $65.0K | 11,933 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | P Buy | 2014-08-27 | 2014-08-29 | 10,000 | $6.50 | $65.0K | 21,933 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2014-07-17 | 2014-07-21 | 551 | — | $0 | 551 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2014-07-17 | 2014-07-21 | 452 | — | $0 | 452 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2014-06-12 | 2014-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2014-05-21 | 2014-05-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MDCO MEDICINES CO /DE | F Tax w/h | 2014-03-03 | 2014-03-04 | 3,549 | $30.10 | $106.8K | 135,024 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award deriv | 2014-03-01 | 2014-03-04 | 57,736 | — | $0 | 57,736 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2014-03-01 | 2014-03-04 | 26,383 | — | $0 | 138,573 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2014-02-28 | 2014-03-04 | 392 | $25.97 | $10.2K | 112,190 | SEC↗ |
| MDCO MEDICINES CO /DE | F Tax w/h | 2014-02-25 | 2014-02-27 | 4,142 | $30.49 | $126.3K | 111,798 | SEC↗ |
| MDCO MEDICINES CO /DE | F Tax w/h | 2014-02-20 | 2014-02-21 | 935 | $29.73 | $27.8K | 115,940 | SEC↗ |
| MDCO MEDICINES CO /DE | F Tax w/h | 2014-02-19 | 2014-02-21 | 1,530 | $29.99 | $45.9K | 116,875 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2013-12-05 | 2013-12-06 | 326 | — | $0 | 0 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-12-05 | 2013-12-06 | 326 | $38.50 | $12.6K | 118,405 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2013-12-05 | 2013-12-06 | 326 | $20.11 | $6.6K | 118,731 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2013-12-04 | 2013-12-06 | 8,190 | — | $0 | 326 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2013-12-04 | 2013-12-06 | 8,190 | $20.11 | $164.7K | 126,595 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-12-04 | 2013-12-06 | 8,190 | $38.50 | $315.3K | 118,405 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2013-11-18 | 2013-11-20 | 16,484 | — | $0 | 8,516 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-11-18 | 2013-11-20 | 16,484 | $38.50 | $634.6K | 118,405 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2013-11-18 | 2013-11-20 | 16,484 | $20.11 | $331.5K | 134,889 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-11-14 | 2013-11-18 | 1,667 | $38.00 | $63.3K | 118,405 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2013-10-25 | 2013-10-29 | 25,000 | — | $0 | 0 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-10-25 | 2013-10-29 | 574 | $35.89 | $20.6K | 120,072 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2013-10-25 | 2013-10-29 | 25,000 | $17.04 | $426.0K | 145,072 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-10-25 | 2013-10-29 | 25,000 | $35.69 | $892.3K | 120,072 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2013-10-23 | 2013-10-25 | 6,949 | — | $0 | 22,033 | SEC↗ |
| OPHT Ophthotech Corp. | P Buy | 2013-09-30 | 2015-07-20 | 1,000 | $22.00 | $22.0K | 1,000 | SEC↗ |
| MDCO MEDICINES CO /DE | J Other | 2013-08-30 | 2013-09-03 | 212 | $26.77 | $5.7K | 120,646 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2013-06-13 | 2013-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-05-10 | 2013-05-13 | 2,709 | $37.00 | $100.2K | 120,434 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award deriv | 2013-03-01 | 2013-03-05 | 36,896 | $31.49 | $1.16M | 36,896 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2013-03-01 | 2013-03-05 | 37,345 | — | $0 | 123,143 | SEC↗ |
| MDCO MEDICINES CO /DE | J Other | 2013-02-28 | 2013-03-05 | 474 | $22.39 | $10.6K | 85,798 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-02-26 | 2013-02-26 | 1,033 | $30.85 | $31.9K | 85,324 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-02-25 | 2013-02-26 | 5,580 | $31.16 | $173.9K | 86,357 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2013-02-20 | 2013-02-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-02-20 | 2013-02-21 | 25,000 | $32.51 | $812.8K | 94,730 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2013-02-20 | 2013-02-21 | 25,000 | $20.11 | $502.8K | 119,730 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-02-20 | 2013-02-22 | 2,793 | $32.42 | $90.5K | 91,937 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-02-19 | 2013-02-21 | 2,552 | $31.81 | $81.2K | 94,730 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2013-01-16 | 2013-01-17 | 25,000 | — | $0 | 24,495 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2013-01-16 | 2013-01-17 | 100,000 | — | $0 | 50,000 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-01-16 | 2013-01-17 | 25,000 | $30.00 | $750.0K | 97,282 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2013-01-16 | 2013-01-17 | 100,000 | $20.11 | $2.01M | 197,282 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-01-16 | 2013-01-17 | 100,000 | $30.00 | $3.00M | 97,282 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2013-01-16 | 2013-01-17 | 25,000 | $19.36 | $484.0K | 122,282 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2013-01-08 | 2013-01-10 | 25,000 | — | $0 | 49,495 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2013-01-08 | 2013-01-10 | 25,000 | $19.36 | $484.0K | 122,282 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2013-01-08 | 2013-01-10 | 25,000 | $28.07 | $701.8K | 97,282 | SEC↗ |
| MDCO MEDICINES CO /DE | J Other | 2012-08-31 | 2012-09-04 | 405 | $18.44 | $7.5K | 97,282 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2012-08-10 | 2012-08-14 | 25,000 | — | $0 | 65,000 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2012-08-10 | 2012-08-14 | 25,000 | $25.15 | $628.8K | 96,877 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2012-08-10 | 2012-08-14 | 8,989 | $25.09 | $225.5K | 96,877 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2012-08-10 | 2012-08-14 | 25,000 | $17.45 | $436.3K | 121,877 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2012-07-25 | 2012-07-27 | 25,000 | — | $0 | 74,495 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2012-07-25 | 2012-07-27 | 25,000 | $19.36 | $484.0K | 130,866 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2012-07-25 | 2012-07-27 | 25,000 | $25.15 | $628.8K | 105,866 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2012-06-13 | 2012-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2012-03-19 | 2012-03-21 | 625 | — | $0 | 15,625 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2012-03-19 | 2012-03-21 | 625 | $7.31 | $4.6K | 106,491 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2012-03-19 | 2012-03-21 | 625 | $20.39 | $12.7K | 105,866 | SEC↗ |
| MDCO MEDICINES CO /DE | J Other | 2012-03-01 | 2012-03-05 | 883 | $12.03 | $10.6K | 105,866 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award deriv | 2012-02-24 | 2012-02-28 | 68,000 | $22.04 | $1.50M | 68,000 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2012-02-24 | 2012-02-28 | 42,500 | $22.04 | $936.7K | 104,983 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise deriv | 2012-02-21 | 2012-02-23 | 625 | $7.31 | $4.6K | 16,250 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2012-02-21 | 2012-02-23 | 625 | $21.03 | $13.1K | 62,483 | SEC↗ |
| MDCO MEDICINES CO /DE | M Exercise | 2012-02-21 | 2012-02-23 | 625 | $7.31 | $4.6K | 63,108 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2012-02-21 | 2012-02-23 | 1,781 | $20.94 | $37.3K | 62,483 | SEC↗ |
| MDCO MEDICINES CO /DE | S Sale | 2012-02-21 | 2012-02-23 | 833 | $20.94 | $17.4K | 64,264 | SEC↗ |